{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:57:56Z","timestamp":1760144276867,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.rmr.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:05:50Z","timestamp":1659045950000},"page":"621-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic d\u2019une granulomatose \u00e9osinophilique avec polyang\u00e9ite sous benralizumab"],"prefix":"10.1016","volume":"39","author":[{"given":"A.","family":"Carrette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lelubre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pech\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2022.06.004_bib0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"key":"10.1016\/j.rmr.2022.06.004_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022\u00a0American college of rheumatology\/european alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2022.06.004_bib0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","article-title":"The roles of IL-5\u00a0and anti-IL-5\u00a0treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.rmr.2022.06.004_bib0080","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.06.004_bib0085","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaip.2020.09.054","article-title":"Benralizumab as a steroid-sparing treatment option in eosinophilic granulomatosis with polyangiitis","volume":"9","author":"Guntur","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.06.004_bib0090","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.06.004_bib0095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3\u00a0trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.rmr.2022.06.004_bib0100","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/rheumatology\/keaa572","article-title":"Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5\u00a0pathway inhibitor for severe asthma","volume":"60","author":"Caminati","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.rmr.2022.06.004_bib0105","article-title":"Emergence of extrathoracic manifestations of eosinophilic granulomatosis with polyangiitis during benralizumab treatment","volume":"5","author":"Lim","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.rmr.2022.06.004_bib0110","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.jaip.2020.04.006","article-title":"Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab","volume":"8","author":"Ho\u010devar","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2022.06.004_bib0115","first-page":"100821","article-title":"Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma","volume":"79","author":"Descamps","year":"2021","journal-title":"Respir Med Res"},{"key":"10.1016\/j.rmr.2022.06.004_bib0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.anai.2016.12.003","article-title":"Omalizumab-associated eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","volume":"118","author":"Nazir","year":"2017","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522002352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522002352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:23:41Z","timestamp":1760106221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842522002352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0761842522002352"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2022.06.004","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic d\u2019une granulomatose \u00e9osinophilique avec polyang\u00e9ite sous benralizumab","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}